ADC Therapeutics (ADCT) Change in Cash: 2018-2024
Historic Change in Cash for ADC Therapeutics (ADCT) over the last 7 years, with Dec 2024 value amounting to -$27.6 million.
- ADC Therapeutics' Change in Cash was N/A to -$32.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$48.0 million, marking a year-over-year change of. This contributed to the annual value of -$27.6 million for FY2024, which is 42.43% up from last year.
- According to the latest figures from FY2024, ADC Therapeutics' Change in Cash is -$27.6 million, which was up 42.43% from -$48.0 million recorded in FY2023.
- ADC Therapeutics' 5-year Change in Cash high stood at $323.4 million for FY2020, and its period low was -$139.9 million during FY2022.
- Over the past 3 years, ADC Therapeutics' median Change in Cash value was -$48.0 million (recorded in 2023), while the average stood at -$71.9 million.
- As far as peak fluctuations go, ADC Therapeutics' Change in Cash soared by 1,487.01% in 2020, and later slumped by 611.63% in 2022.
- ADC Therapeutics' Change in Cash (Yearly) stood at $323.4 million in 2020, then tumbled by 91.55% to $27.3 million in 2021, then slumped by 611.63% to -$139.9 million in 2022, then surged by 65.67% to -$48.0 million in 2023, then soared by 42.43% to -$27.6 million in 2024.